The activity of renin-angiotensin system in patients with arterial hypertension in population of the Gornaia Shoria
- Authors: Mulerova T.A.1,2, Uchasova E.G1, Chigisova A.N1, Ogarkov M.Y.1,2
-
Affiliations:
- The research institute of complex problems of cardiovascular diseases
- The Novokuznetskiy state institute of post-graduate training of physicians of Minzdrav of Russia
- Issue: Vol 22, No 3 (2016)
- Pages: 129-133
- Section: Articles
- URL: https://journals.rcsi.science/0869-2106/article/view/38316
- DOI: https://doi.org/10.18821/0869-2106-2016-22-3-129-133
- ID: 38316
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Tatiana A. Mulerova
The research institute of complex problems of cardiovascular diseases; The Novokuznetskiy state institute of post-graduate training of physicians of Minzdrav of Russia
Email: mulerova-77@mail.ru
candidate of medical sciences, research fellow of laboratory of epidemiology of the Research institute of complex problems of cardiovascular diseases; assistant of chair of cardiology of the Novokuznetskiy state institute of post-graduate training of physicians Kemerovo, Russia
E. G Uchasova
The research institute of complex problems of cardiovascular diseasesKemerovo, Russia
A. N Chigisova
The research institute of complex problems of cardiovascular diseasesKemerovo, Russia
M. Yu Ogarkov
The research institute of complex problems of cardiovascular diseases; The Novokuznetskiy state institute of post-graduate training of physicians of Minzdrav of RussiaKemerovo, Russia
References
- Paul M., Mehr A.P., Kreutz R. Physiology of local renin-angiotensin systems. Physiol. Rev. 2006; 86 (3): 747-803.
- Sealey J.E., Parra D., Rosenstein R., Laragh J.H. "Effective" plasma renin activity: a derived measure for assessing residual plasma renin activity in patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Hypertension. 2010; 55 (3): е16.
- Furberg C.D. Renin-guided treatment of hypertension: time for action. Am. J. Hypertens. 2010; 23 (9): 929-30.
- Walmor C. DeMello, Edward D. Frohlich. Renin Angiotensin System and Cardiovascular Disease. USA: Humana press; 2009; 27: 35-59.
- Leung P.S. The peptide hormone angiotensin II: its new functions in tissues and organs. Curr. Protein Pept. Sci. 2004; 5: 267-73.
- Gibbons G.H. The pathophysiology of hypertension: The importance of angiotensin II in cardiovascular remodeling. Am. J. Hypertens. 1998; 11 (8): 177-81.
- Laragh J.H. Laragh’s Lessons in Renin System Pathophysiology for Treating Hypertension and its Fatal Cardiovascular Consequences. New York: Elsevier Science; 2002.
- Laragh J.H., Sealey J.E. The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure. Am. J. Hypertens. 2011; 24 (11): 1164-80.
- Laragh J.H. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am. J. Med. 1973; 55 (3): 261-74.
- Laragh J.H. Laragh’s lessons in pathophysiology and clinical pearls for treating hypertension. Am. J. Hypertens. 2001; 14 (12): 733-42.
- Чазова И.Е. Российская многоцентровая программа ПРИЗ изучение антигипертензивной эффективности периндоприла в широкой клинической практике. Consilium medicum. 2002; 4 (3): 125-30.
- Furberg C.D. Renin test-guided drug treatment of hypertension: the need for clinical trials. Am. J. Hypertens. 2011; 24 (11): 1158-63.
- Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E. Sachs I. et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am. J. Cardiol. 1986; 57 (6): 450-8.
- Tigerstedt R., Bergmann P.G. Niere und kreislauf. Scand. Arch. Physiol. 1898; 8: 223-71.
- Ganong W.F., Davis J.O., Sambhi M.P. Symposium on control of renin secretion. J. Hypertens. 1984; 2 (Suppl. 1): 1-153.
- Castrop H., Höcherl K., Kurtz A., Schweda F., Todorov V., Wagner C. Physiology of kidney renin. Physiol. Rev. 2010; 90 (2): 607-73.
- Furberg C.D. Treatment of hypertension: a failing report card. Am. J. Hypertens. 2009; 22 (1): 1-2.
- Laragh J., Sealey J.E. Relevance of the plasma renin hormonal control system that regulates blood pressure and sodium balance for correctly treating hypertension and for evaluating ALLHAT. Am. J. Hypertens. 2003; 16 (5, Pt. 1): 407-15.
- Obarzanek E., Proschan M.A., Vollmer W.M., Moore T.J., Sacks F.M., Appel L.J. et al. Individual blood pressure responses to changes in salt intake: results from the DASH-Sodium trial. Hypertension. 2003; 42 (4): 459-67.
- Кравцова О.А. Значение активности ренина плазмы для профилирования и оптимизации лечения артериальной гипертонии: Дисc. ... канд. мед. наук. М.; 2014.
- Sim J.J., Bhandari S.K., Shi J., Kalantar-Zadeh K., Rasgon S.A., Sealey J.E. et al. Plasma renin activity (PRA) levels and antihypertensive drug use in a large healthcare system. Am. J. Hypertens. 2012; 25 (3): 379-88.
- Котовская Ю.В., Кравцова О.А., Павлова Е.А. Определение активности ренина плазмы как стратегия выбора и изменения антигипертензивной терапии. Артериальная гипертензия. 2013; 19 (5): 380-8.
- Campbell D.J., Woodward M., Chalmers J.P., Colman S.A., Jenkins A.J., Kemp B.E. et al. Prediction of myocardial infarction by N-terminal-Pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease. Circulation. 2005; 112 (1): 110-6.
- Sechi L.A., Novello M., Colussi G., Di Fabio A., Chiuch A., Nadalini E. et al. Relationship of plasma renin with a prothrombotic state in hypertension: relevance for organ damage. Am. J. Hypertens. 2008; 21 (12): 1347-53.
- Gonzalez M.C., Cohen H.W., Sealey J.E., Laragh J.H., Alderman M.H. Enduring direct association of baseline plasma renin activity with all-cause and cardiovascular mortality in hypertensive patients. Am. J. Hypertens. 2011; 24 (11): 1181-6.